Furthermore, prothrombin induced by vitamin K absence-II (PIVKA-II), also known as des-gamma-carboxyprothrombin (DCP), has been proven to be not only a specific tumor marker but also a predictor of prognosis for hepatocellular carcinoma (HCC) [16]. Here, ACE is linked to hepatocellular carcinoma.